Braintale develops and distributes diagnosis and prognosis tools for brain injured patients.
BrainTale has raised €5.5M across 2 funding rounds from 2 investors, most recently a round in Jun 2023. Based in Paris, France; founded 2018; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-06-20 | Other | €4.5M | Capital Grand Est,MACSF | View deal → |
| 2020-11-10 | Other | €1.0M | — | View deal → |
